Clinical Trials Directory

Trials / Unknown

UnknownNCT02992769

Predict the Risk of Axillary Metastases in Breast Cancer Patients With Axillary Ultrasound

A Nomogram to Predict the Risk of Axillary Metastases in Breast Cancer Patients With Axillary Ultrasound

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
Sex
Female
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Axillary lymph node status is a vital prognostic factors in breast cancer patients and provides crucial information for making treatment decisions.This projective observational study is planned to identify risk factors for axillary metastases in breast cancer patients with axillary ultrasound and to construct a nomogram to predict the risk of axillary metastases in these patients.

Detailed description

Breast carcinoma is the most common malignancy in women, accounting for 25% of all female cancer cases and 15% of all cancer-related deaths in the world.Lymph node metastasis is a multifactorial event. Among patients with a preoperative axillary ultrasound, almost 40% of patients are pathologically proved to be free from axillary metastasis.The purpose of this study is to develop a nomogram to evaluate the probability of axillary metastasis as a tool to support clinical decision-making.

Conditions

Timeline

Start date
2016-03-01
Primary completion
2017-09-01
Completion
2017-09-01
First posted
2016-12-14
Last updated
2016-12-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02992769. Inclusion in this directory is not an endorsement.

Predict the Risk of Axillary Metastases in Breast Cancer Patients With Axillary Ultrasound (NCT02992769) · Clinical Trials Directory